Posts Tagged: "LexisNexis IP"

  Looking at the patent landscape of antibiotics to identify global leaders As the global research community is scrambling to develop solutions and help the world recover from the impact of Covid-19, we should not stay blind to other medical risks on the horizon which should be addressed. Chief among these is drug resistant bacteria, a risk which could potentially…

It is well understood that most of the technology products of the world are not ultimately produced in the same country from which the inventions themselves originated. For e.g. in the case of LED and lithium-ion batteries (LIB) the early stages of development of the technology were conducted in US/JP/EU, then adopted and scaled in KR/TW, and are now being…

  What is the difference between class 705 and class 706? There is much more than a single number, and in some instances whether your patent application is primarily lodged in class 705 instead of 706 that could likely mean you will be routed to an Art Unit with a very low, perhaps extremely low, allowance rate. In a nutshell,…

There is wide examiner variability at the USPTO, understanding this and how it affects the prosecution process and outcomes is of the utmost importance for patent practitioners. Discover the impact of the type of examiner by exploring important milestones in the life cycle of a U.S. patent application through historical trends and counter-intuitive results. This webinar will help you to…

In this webinar, a panel consisting of leaders in academic innovation research and industrial innovation experts, define a world-class patent portfolio from their perspectives. They will also discuss how to implement processes in organisations to develop and maintain such a patent portfolio. By combining these perspectives, the discussion will arrive at the requirements for software applications that are capable to…

We all know that some art units are more difficult than others, so just knowing which art unit your application will be assigned to can give you better insight. In-depth art unit insight including knowing your chances of ending up with a fast, medium or slow examiner in that art unit.  Knowing the likelihood of if, and when, your patent…

Worldwide, billions of dollars are spent to protect technologies and products through patents. What at first glance, appears to be a vital and profitable investment for companies can, over time, turn into a cost trap. Why? 1. Companies tend to protect too much rather than too little. 2. The maintenance of patent protection is hardly ever questioned. Companies have to…

What do Tom Hanks, Rand Paul, Idris Elba, and Boris Johnson have in common? They are just some of the high-profile people to be diagnosed with the COVID-19. Proof that SARS-CoV2 can affect anyone. The situation is dire. In many places, hospitals are overwhelmed, and the healthcare system is overworked, overburdened, and barely hanging on. Models currently being used by…